Talent equity
RSA Talent Talks debut Podcast
We’re seeing some of the most exciting new therapeutics emerge from the Cell & Gene Therapy Sector, it’s happening quickly and delivering meaningful results...
What next for EU and UK biotech boards?
In light of the UK’s decision to leave the EU, it’s worth revisiting our recent Talent Equity® report on what makes successful biotech boards. The question...
Talent: the key to biotech value creation
Everyone’s happy to talk about how important talent is to tech and life sciences companies but when it comes to valuation the financial community...
New management talent needed to support biotech renaissance
2014 saw VCs plough $6.55bn into the biotech sector, with Europe alone seeing a year-on-year increase of $1.24bn. The figures tell a story of...